S&P 500
(0.86%) 5 248.49 points
Dow J
(1.22%) 39 760 points
Nasdaq
(0.51%) 16 400 points
Oil
(1.25%) $82.37
Gas
(1.05%) $1.736
Gold
(0.45%) $2 222.60
Silver
(-0.19%) $24.71
Platinum
(0.99%) $918.75
USD/EUR
(0.17%) $0.925
USD/NOK
(0.51%) $10.82
USD/GBP
(-0.04%) $0.791
USD/RUB
(0.42%) $92.83

Realtime updates for Hemogenyx Pharmaceuticals [HEMO.L]

Exchange: LSE Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated28 Mar 2024 @ 09:49

-1.16% £ 1.742

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 09:49):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases...

Stats
Today's Volume 4.13M
Average Volume 15.23M
Market Cap 23.37M
EPS £0 ( 2023-09-27 )
Next earnings date ( £0 ) 2024-04-25
Last Dividend £0 ( N/A )
Next Dividend £0 ( N/A )
P/E -1.740
ATR14 £0.0160 (0.92%)

Volume Correlation

Long: 0.00 (neutral)
Short: 0.29 (neutral)
Signal:(49.075) Neutral

Hemogenyx Pharmaceuticals Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hemogenyx Pharmaceuticals Correlation - Currency/Commodity

The country flag -0.26
( neutral )
The country flag -0.06
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.14
( neutral )

Hemogenyx Pharmaceuticals Financials

Annual 2022
Revenue: £0
Gross Profit: £-2.60M (0.00 %)
EPS: £-0.00440
Q2 2023
Revenue: £0
Gross Profit: £-319 909 (0.00 %)
EPS: £-0.00410
Q1 2023
Revenue: £0
Gross Profit: £0 (0.00 %)
EPS: £-0.00210
Q4 2022
Revenue: £0
Gross Profit: £-531 839 (0.00 %)
EPS: £-0.00290

Financial Reports:

No articles found.

Hemogenyx Pharmaceuticals

Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. It is involved in developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML), subset of acute lymphoblastic leukaemia, and myelodysplastic syndrome conditioning bone marrow transplants to substitute traditional chemotherapy and/or radiation; HEMO-CAR-T therapy, a chimeric antigen receptor T-cells to identify and destroy human AML-derived cells in vitro and in vivo; and Human Postnatal Hematopoietic Endothelial Cells, a stem cell therapy product for BM/HSC transplants. The company was founded in 2012 and is headquartered in London, the United Kingdom.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators